1. Home
  2. SNSE vs MHUA Comparison

SNSE vs MHUA Comparison

Compare SNSE & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • MHUA
  • Stock Information
  • Founded
  • SNSE 2005
  • MHUA 1990
  • Country
  • SNSE United States
  • MHUA China
  • Employees
  • SNSE N/A
  • MHUA N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • SNSE Health Care
  • MHUA Health Care
  • Exchange
  • SNSE Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • SNSE 14.5M
  • MHUA 12.7M
  • IPO Year
  • SNSE 2021
  • MHUA 2022
  • Fundamental
  • Price
  • SNSE $9.10
  • MHUA $0.23
  • Analyst Decision
  • SNSE Strong Buy
  • MHUA
  • Analyst Count
  • SNSE 5
  • MHUA 0
  • Target Price
  • SNSE $72.50
  • MHUA N/A
  • AVG Volume (30 Days)
  • SNSE 77.5K
  • MHUA 684.1K
  • Earning Date
  • SNSE 11-07-2025
  • MHUA 12-19-2025
  • Dividend Yield
  • SNSE N/A
  • MHUA N/A
  • EPS Growth
  • SNSE N/A
  • MHUA N/A
  • EPS
  • SNSE N/A
  • MHUA 0.29
  • Revenue
  • SNSE N/A
  • MHUA $89,547,563.00
  • Revenue This Year
  • SNSE N/A
  • MHUA N/A
  • Revenue Next Year
  • SNSE N/A
  • MHUA N/A
  • P/E Ratio
  • SNSE N/A
  • MHUA $0.78
  • Revenue Growth
  • SNSE N/A
  • MHUA N/A
  • 52 Week Low
  • SNSE $5.00
  • MHUA $0.21
  • 52 Week High
  • SNSE $18.35
  • MHUA $0.76
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 44.91
  • MHUA 34.19
  • Support Level
  • SNSE $8.33
  • MHUA $0.22
  • Resistance Level
  • SNSE $9.45
  • MHUA $0.28
  • Average True Range (ATR)
  • SNSE 1.00
  • MHUA 0.04
  • MACD
  • SNSE -0.27
  • MHUA -0.00
  • Stochastic Oscillator
  • SNSE 18.90
  • MHUA 16.71

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: